semaglutide linked to cancer Could medications like Ozempic someday become part of treatment? A new Phase II clinical trial launching in 2026 is studying whether adding GLP-1 medications like standard rectal cancer therapy Disproportionality analysis of semaglutide-associated bile-duct

Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry

Results showed that both L-glutathione or L-cysteine lightened skin on the upper forearm, and reduced the color of dark spots on the face

Cumulative incidence of NAION was estimated using the Kaplan-Meier method

Switching from orforglipron to an injectable GLP-1 is simpler pharmacokinetically, since orforglipron's effects clear within a day or two of the last dose

Understanding the relationship between incretin-based therapies and gallbladder health is essential for safe, effective treatment